Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Elliott Associates Makes Next Move In Samsung Battle

Page 1 of 2

Elliott Associates, L.P., managed by billionaire Paul Elliott Singer, is continuing to intensify its effort to hinder the merger of two Samsung Group companies. The proposed $8-billion transaction is considered key in the generational transfer of power of the founding Lee family, however, Paul Singer and at least some of the shareholders of Samsung C&T, the company to be acquired, feel the deal undervalues the company and should not be approved. Furthermore, influential proxy advisers Glass Lewis & Co. and Institutional Shareholder Services Inc. (ISS) urged shareholders to reject the merger of Samsung C&T Corp. and Cheil Industries Inc. in separate announcements last Thursday and Friday respectively. Singer made his latest move to attempt to prevent the merger from happening yesterday, as he purchased a 1% stake in Samsung Fire & Marine Insurance Co. Ltd., confirmed by a spokeswoman of said company. The move gives Singer a little more voting power in the upcoming shareholder vote that will decide the fate of the merger deal.


Following activist funds like Elliott Associates is important because it is a very specific and focused strategy in which the investor doesn’t have to wait for catalysts to realize gains in the holding. A fund like Paul Singer’s can simply create its own catalysts by pushing for them through negotiations with the company’s management and directors. In recent years, the average returns of activists’ hedge funds has been much higher than the returns of an average hedge fund. Furthermore, we believe do-it-yourself investors have an advantage over activist hedge fund investors because they don’t have to pay 2% of their assets and 20% of their gains every year to compensate hedge fund managers. We have found through extensive research that the top small-cap picks of hedge funds are also capable of generating high returns and built a system around this premise. In the 32 months since our small-cap strategy was launched it has returned over 135% and beaten the S&P 500 ETF (SPY) by more than 80 percentage points (read more details). Soon, we’ll be releasing a new quarterly newsletter written by former activist hedge fund analyst Michael Bland that tracks ten or so activist campaigns at any given time.

Paul Singer
Paul Singer
Elliott Management

The merger of the two Samsung Group affiliate firms, which will go to a shareholder vote on July 17th, is the latest move by the Lee family to try and solidify their clan’s control, held through a complex cross-shareholding structure, over Korea’s largest family-ruled conglomerate or chaebol, which spans 67 companies. Lee Jae Yong, Samsung Group’s heir apparent and the son of now bedridden Chairman Lee Kun-hee, is the majority shareholder of Cheil Industries Inc., the de facto holding firm of the group. The expected change of leadership comes after the group’s chairman and the son of the group’s founder, Lee Byung-chul, suffered a major heart attack last year.

Elliott Associates has a 7.1% stake in Samsung C&T and a 1% stake in Samsung SDI Co. Ltd. which is an affiliate that also owns shares of Samsung C&T. Samsung Fire & Marine Insurance Co. Ltd. is also a shareholder of Samsung C&T. Samsung C&T, in turn, owns 4.1% of Samsung Electronics, the flagship affiliate of the group, which the Lee family owns less than 5% of. The merger between Samsung C&T and Cheil Industries will boost the Lee family’s stake in Samsung Electronics. Lee Kun-hee’s children are consolidating their family’s interests in the chaebol to smoothen the younger generation Lee family members’ transition into controlling the conglomerate.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!